Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bioverativ Inc. (BIVV) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bioverativ Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1681689.
Total stock buying since 2017: $56,742,594.
Total stock sales since 2017: $49,464.
Total stock option exercises since 2017: $175,170.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2018 | 0 | $0 | 0 | $0 | 69,570 | $175,170 |
| 2017 | 1,017,000 | $56,742,594 | 818 | $49,464 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2018-02 | 0 | $0 | 0 | $0 | 69,570 | $175,170 |
| 2017-08 | 3,000 | $178,590 | 0 | $0 | 0 | $0 |
| 2017-06 | 0 | $0 | 818 | $49,464 | 0 | $0 |
| 2017-05 | 1,014,000 | $56,564,004 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-02-14 | Duvall Diantha (Chief Accounting Officer) | Option Ex | 1,390 | .00 | 0 |
| 2018-02-14 | Difabio Andrea (EVP, Chief Legal Officer) | Option Ex | 3,744 | .00 | 0 |
| 2018-02-14 | Celona Lucia (EVP, HR & Corp Commun. Officer) | Option Ex | 3,744 | .00 | 0 |
| 2018-02-14 | Brudnick Richard (EVP, Business Development) | Option Ex | 3,744 | .00 | 0 |
| 2018-02-14 | Greene John (EVP, CFO and Treasurer) | Option Ex | 7,114 | .00 | 0 |
| 2018-02-14 | Vivaldi Coelho Rogerio (EVP, Chief Global Therapeutics) | Option Ex | 7,114 | .00 | 0 |
| 2018-02-14 | Cox John (Chief Executive Officer) | Option Ex | 24,339 | .00 | 0 |
| 2018-02-11 | Cox John (Chief Executive Officer) | Option Ex | 18,381 | 9.53 | 175,170 |
| 2017-08-09 | Posner Brian S (Director) | Buy | 1,000 | 59.19 | 59,190 |
| 2017-08-07 | Paglia Louis J (Director) | Buy | 2,000 | 59.70 | 119,400 |
| 2017-06-28 | Duvall Diantha (Chief Accounting Officer) | Sale | 818 | 60.47 | 49,464 |
| 2017-05-30 | Denner Alexander J (Director) | Buy | 90,000 | 55.93 | 5,033,520 |
| 2017-05-26 | Denner Alexander J (Director) | Buy | 450,000 | 57.21 | 25,744,950 |
| 2017-05-26 | Paglia Louis J (Director) | Buy | 2,000 | 57.76 | 115,520 |
| 2017-05-25 | Denner Alexander J (Director) | Buy | 130,000 | 54.98 | 7,147,920 |
| 2017-05-24 | Posner Brian S (Director) | Buy | 2,000 | 53.85 | 107,694 |
| 2017-05-24 | Denner Alexander J (Director) | Buy | 340,000 | 54.16 | 18,414,400 |
Insider trading activities including stock purchases, stock sales, and option exercises of BIVV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bioverativ Inc. (symbol BIVV, CIK number 1681689) see the Securities and Exchange Commission (SEC) website.